EUVIMEDEUVIMED entdecken
Crossref

Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies

L Ferri, V Menghi, L Licchetta, P Dimartino, R Minardi, C Davì, L Di Vito, E Cifaldi, C Zenesini, F Gozzo, V Pelliccia, V Mariani und 6 weitere

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von L Ferri und 17 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (full member of the European Reference Network EpiCARE), Via Altura 3, Bologna …. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Epilepsies, Partial, Malformations of Cortical Development, Epilepsy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study investigates the prevalence of pathogenic variants in the mechanistic target of rapamycin (mTOR) pathway in surgical specimens of malformations of cortical development (MCDs) and cases with negative histology. The study also aims to evaluate the predictive value of genotype-histotype findings on the surgical outcome. METHODS: The study included patients with drug-resistant focal epilepsy who underwent epilepsy surgery. Cases were selected based on histopathological diagnosis, focusing on MCDs and negative findings. We included brain tissues both as formalin-fixed, paraffin-embedded (FFPE) or fresh frozen (FF) samples. Single-molecule molecular inversion probes (smMIPs) analysis was conducted, targeting the MTOR gene in FFPE samples and 10 genes within the mTOR pathway in FF samples. Correlations between genotype-histotype and surgical outcome were examined. RESULTS: We included 78 patients for whom we obtained 28 FFPE samples and 50 FF tissues. Seventeen pathogenic variants (22 %) were identified and validated, with 13 being somatic within the MTOR gene and 4 germlines (2 DEPDC5, 1 TSC1, 1 TSC2). Pathogenic variants in mTOR pathway genes were exclusively found in FCDII and TSC cases, with a significant association between FCD type IIb and MTOR genotype (P = 0.003). Patients carrying mutations had a slightly better surgical outcome than the overall cohort, however it results not significant. The FCDII diagnosed cases more frequently had normal neuropsychological test, a higher incidence of auras, fewer multiple seizure types, lower occurrence of seizures with awareness impairment, less ictal automatisms, fewer Stereo-EEG investigations, and a longer period long-life of seizure freedom before surgery. SIGNIFICANCE: This study confirms that somatic MTOR variants represent the primary genetic alteration detected in brain specimens from FCDII/TSC cases, while germline DEPDC5, TSC1/TSC2 variants are relatively rare. Systematic screening for these mutations in surgically treated patients' brain specimens can aid histopathological diagnoses and serve as a biomarker for positive surgical outcomes. Certain clinical features associated with pathogenic variants in mTOR pathway genes may suggest a genetic etiology in FCDII patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyEpilepsies, PartialMalformations of Cortical DevelopmentEpilepsyMalformations of Cortical Development, Group IAdultHumansTOR Serine-Threonine KinasesSeizuresGerm Cells

Stichwörter der Autor:innen

Epilepsy surgeryFocal Cortical DysplasiaHistopathological diagnosisSomatic mutationsSurgical OutcomemTOR pathway

Substanzen

TOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (full member of the European Reference Network EpiCARE), Via Altura 3, Bologna 40139, Italy; Department of Biomedical and NeuroMotor Sciences, Univer…
  • Department of Biomedical and NeuroMotor Sciences, University of Bologna, Via Massarenti, 9 - Pad. 11 - 40138 Bologna, Italy; Neurology Unit, Rimini "Infermi" Hospital-AUSL Romagna, Rimini, Italy.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Epilepsy Center (full member of the European Reference Network EpiCARE), Via Altura 3, Bologna 40139, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti, 9 - Pad. 11 - 40138 Bologna, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.
  • Claudio Munari Epilepsy Surgery Center, Niguarda Hospital, Milano, Italy.

Förderung

  • Ministero della Salute

Zitieren

APA

Ferri, L., Menghi, V., Licchetta, L., Dimartino, P., Minardi, R., Davì, C., Di Vito, L., Cifaldi, E., Zenesini, C., Gozzo, F., Pelliccia, V., Mariani, V., de Spelorzi, Y. C. C., Gustincich, S., Seri, M., Tassi, L., Pippucci, T., & Bisulli, F. (2024). Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109716

Vancouver

Ferri L, Menghi V, Licchetta L, Dimartino P, Minardi R, Davì C, et al. Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109716

BibTeX
@article{Ferri2024,
  author = {Ferri, L and Menghi, V and Licchetta, L and Dimartino, P and Minardi, R and Davì, C and Di Vito, L and Cifaldi, E and Zenesini, C and Gozzo, F and Pelliccia, V and Mariani, V and de Spelorzi, Y C C and Gustincich, S and Seri, M and Tassi, L and Pippucci, T and Bisulli, F},
  title = {Detection of somatic and germline pathogenic variants in adult cohort of drug-resistant focal epilepsies},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109716}
}
Kostenlos starten →